Summary

Eligibility
for people ages 50 years and up (full criteria)
Healthy Volunteers
healthy people welcome
Location
at UCLA
Dates
study started
completion around
Principal Investigator
by Monica Kelly, PhD (ucla)
Headshot of Monica Kelly
Monica Kelly

Description

Summary

This pilot pre-post trial will address a gap in knowledge related to addressing modifiable risk factors for cardiometabolic disease through treating residual insomnia, sleep difficulties that remain after successful treatment of another condition, in the context of PTSD in understudied older adults. This study provides a non-medication treatment for PTSD called Cognitive Processing Therapy (CPT) followed by a non-medication sleep education and treatment program (Cognitive Behavioral Therapy for Insomnia, CBT-I) for sleep problems that remain after completing PTSD treatment in older adults with PTSD. The aims of this project are to evaluate 1) the added benefits of treating residual insomnia on sleep and PTSD symptoms; 2) the added benefits of treating residual insomnia following CPT on cardiometabolic risk biomarkers and quality of life; and 3) the durability of the sleep, PTSD, cardiometabolic and quality of life benefits of treating residual insomnia following CPT at 6-month follow-up in older adults with PTSD.

Details

Keywords

Posttraumatic Stress Disorder, Insomnia, Cardiovascular Diseases, Metabolic Disease, Quality of Life, Sleep Initiation and Maintenance Disorders, Metabolic Diseases, Traumatic Stress Disorders, Post-Traumatic Stress Disorders, Behavioral Sleep Education Intervention

Eligibility

Location

  • VA Greater Los Angeles Healthcare System accepting new patients
    North Hills California 91343 United States

Lead Scientist at University of California Health

  • Monica Kelly, PhD (ucla)
    Assistant Professor-in-Residence, Medicine. Authored (or co-authored) 20 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Los Angeles
ID
NCT05516277
Study Type
Interventional
Participants
Expecting 167 study participants
Last Updated